NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Disclosure Remove constraint Subjects: Disclosure

Search Results

2. Managing conflict of interest in AHCs to assure healthy industrial and societal relationships

3. Snapshots of recent state initiatives in Medicaid prescription drug cost control

8. Quarterly update on preventing wrong-site surgery

9. Quarterly update on preventing wrong-site surgery

12. Quarterly update: what body parts and procedures are associated with wrong-site surgery?

13. Spending on shoppable services in health care

14. Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests

15. Embracing accountability: physician leadership, public reporting, and teamwork in the Wisconsin Collaborative for Healthcare Quality

16. A high performance health system for the United States: an ambitious agenda for the next president

17. Health care opinion leaders' views on transparency and pricing

18. Health care price transparency and price competition

24. Beyond the count: preventing retention of foreign objects

25. Program integrity after the enactment of health reform

27. Neuromuscular blocking agents: reducing associated wrong-drug errors

29. Medication errors in labor and delivery: reducing maternal and fetal harm

30. Preventing maternal and neonatal harm during vacuum-assisted vaginal delivery

31. Neonatal complications: recognition and prompt treatment of shoulder dystocia

35. Safe intrahospital transport of the non-ICU patient using standardized handoff communication

36. Safety in the MR environment: MR safety screening practices

40. Quarterly update on the Preventing Wrong-Site Surgery Project

41. Quarterly update on the Preventing Wrong-Site Surgery Project: digging deeper

42. Price transparency efforts accelerate: what hospitals and other stakeholders are doing to support consumers

43. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

44. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters

45. Understanding the market for implantable medical devices

47. COVID-19: federal efforts accelerate vaccine and therapeutic development, but more transparency needed on emergency use authorizations : report to Congressional addressees

49. Public reporting and transparency

50. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements: guidance for industry